Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 5/20 | 0.33 |
| ▸ | PRKCA | P17252 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4448964 | 0.87 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL2468781 | 0.86 | ATM (0.50) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9847148 | 0.85 | ATM (0.46) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL29248411 | 0.84 | ATM (0.44) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL20875236 | 0.83 | ATM (0.60) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL20913247 | 0.83 | ATM (0.60) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL8669692 | 0.83 | ATM (0.60) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL692095 | 0.83 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL20494858 | 0.82 | ATM (0.43) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL297601 | 0.81 | ATM (0.46) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108003348-B | Siloxane bridged ladder-shaped polysiloxane, preparation method and application thereof | 长兴（中国）投资有限公司 | 2021-02-23 | — | — | CN | disclosed |
| CN-107141427-A | A kind of photochromic composition and its application | 无锡创彩光学材料有限公司 | 2017-09-08 | — | — | CN | disclosed |
| CN-105308074-A | Photochromic curable composition | TOKUYAMA CORP | 2016-02-03 | — | — | CN | disclosed |
| CN-103703029-B | Photochromic curable composition | TOKUYAMA CORP. (JP) | 2016-01-06 | — | — | CN | disclosed |
| CN-104995281-A | Photochromic curable composition | TOKUYAMA CORP | 2015-10-21 | — | — | CN | disclosed |
| US-8299185-B2 | Curable cage-type silicone copolymer and process for production thereof and curable resin composition comprising curable cage-type silicone copolymer and cured product thereof | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-8058261-B2 | 3′-ethynylcytidine derivative | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2011-11-15 | — | — | US | disclosed |
| EP-2045258-B1 | 3'-ETHYNYLCYTIDINE DERIVATIVE | TAIHO PHARMACEUTICAL CO LTD (JP) | 2011-09-21 | — | — | EP | disclosed |
| US-20100280190-A1 | CURABLE CAGE-TYPE SILICONE COPOLYMER AND PROCESS FOR PRODUCTION THEREOF AND CURABLE RESIN COMPOSITION COMPRISING CURABLE CAGE-TYPE SILICONE COPOLYMER AND CURED PRODUCT THEREOF | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-7825103-B2 | 5'-O-triisopropylsilyl-2'-cyano-2'-deoxy-1- beta -D-arabinofuranosylcytosine; antitumor agents | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2010-11-02 | — | — | US | disclosed |
| US-20090118222-A1 | NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-2045258-A1 | 3'-ETHYNYLCYTIDINE DERIVATIVE | Taiho Pharmaceutical Co., Ltd. (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-7319129-B2 | Silsesquioxane derivative and process for producing the same | CHISSO CORPORATION (JP) | 2008-01-15 | — | — | US | disclosed |
| EP-1845102-A1 | NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-10-17 | — | — | EP | disclosed |
| US-20060052623-A1 | Having two cyclotetrasiloxne rings connected by O-Si groups obtained through hydrolysis and condensation of trifunctional hydrolyzable silicon compounds; functionalization; fireproofing, thermostability, weathproofing, photostability, dielectric, hardness, strength and chemical resistance | CHISSO CORPORATION (JP) | 2006-03-09 | — | — | US | disclosed |
| US-6750308-B2 | HEAT RESISTANCE AND LIGHT TRANSMISSION AS TO BE CAPABLE OF SUBSTITUTING FOR GLASS, LOW WATER ABSORPTION, DIMENSIONAL STABILITY AND MOLDABILITY | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2004-06-15 | — | — | US | disclosed |
| EP-0967237-B1 | SILICONE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME | NIPPON STEEL CHEMICAL CO (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030105246-A1 | Heat resistance and light transmission as to be capable of substituting for glass, low water absorption, dimensional stability and moldability | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2003-06-05 | — | — | US | disclosed |
| US-6284858-B1 | Silicone compounds and process for producing the same | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2001-09-04 | — | — | US | disclosed |
| EP-0967237-A1 | SILICONE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME | Nippon Steel Chemical Co., Ltd. (JP) | 1999-12-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052623-A1 | Having two cyclotetrasiloxne rings connected by O-Si groups obtained through hydrolysis and condensation of trifunctional hydrolyzable silicon compounds; functionalization; fireproofing, thermostability, weathproofing, photostability, dielectric, hardness, strength and chemical resistance | STS, PFAS, POLQ | ATM 1682/4885HCAR2 3038/4885MAPT 4617/4885 |
| US-20090118222-A1 | NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT | CDK10, SRSF9, SNRPD1 | ATM 1642/4885HCAR2 3718/4885MAPT 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.